|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
22,000 |
|
|
Direct
Value |
$6,950,507 |
|
|
Indirect Value
|
$160,840 |
|
|
Total
Shares |
315,421 |
|
|
Total
Value |
$7,111,347 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
5
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
-23.4%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-05-24 |
63,339 |
2024-05-24 |
2,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-04-16 |
4 |
OE |
$16.23 |
$162,300 |
D/D |
10,000 |
198,940 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-10-07 |
4 |
OE |
$16.23 |
$973,800 |
D/D |
60,000 |
249,794 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-11-05 |
4 |
OE |
$16.23 |
$162,300 |
D/D |
10,000 |
171,794 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-13 |
4 |
AS |
$16.41 |
$66,674 |
D/D |
(4,063) |
248,794 |
0 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-02-28 |
4 |
A |
$16.61 |
$5,000 |
D/D |
301 |
33,159 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-02-05 |
4 |
AS |
$16.62 |
$41,550 |
D/D |
(2,500) |
248,466 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-12 |
4 |
AS |
$17.16 |
$17,160 |
D/D |
(1,000) |
252,857 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2006-11-29 |
4 |
S |
$17.23 |
$86,150 |
D/D |
(5,000) |
2,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-03 |
4 |
OE |
$17.33 |
$178,690 |
D/D |
10,311 |
41,789 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-25 |
4 |
OE |
$17.33 |
$159,037 |
D/D |
9,177 |
53,155 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-05-26 |
4 |
OE |
$17.33 |
$702,073 |
D/D |
40,512 |
84,490 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-05-15 |
4 |
OE |
$17.33 |
$173,300 |
D/D |
10,000 |
69,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-07-02 |
4 |
OE |
$17.54 |
$1,672,351 |
D/D |
95,345 |
154,375 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2019-05-14 |
4 |
AS |
$17.79 |
$32,698 |
D/D |
(1,838) |
257,804 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2019-05-15 |
4 |
AS |
$17.82 |
$32,753 |
D/D |
(1,838) |
255,966 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2017-06-14 |
4 |
S |
$17.85 |
$89,250 |
D/D |
(5,000) |
245,556 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2015-11-10 |
4 |
AS |
$18.72 |
$561,600 |
D/D |
(30,000) |
308,756 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2015-11-09 |
4 |
AS |
$18.77 |
$563,100 |
D/D |
(30,000) |
338,756 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-04-30 |
4 |
A |
$19.35 |
$19,462 |
D/D |
1,006 |
47,685 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-05-11 |
4 |
S |
$19.58 |
$42,023 |
D/D |
(2,146) |
186,794 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-08-05 |
4 |
AS |
$19.68 |
$49,200 |
D/D |
(2,500) |
236,232 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2007-02-14 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
2,829 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-06-25 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
238,732 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-08-10 |
4 |
S |
$20.21 |
$405,389 |
D/D |
(20,000) |
4,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-02 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
41,271 |
0 |
- |
|
170 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|